| |
Latest 10 SEC filings (by transaction date) for EXAS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 2/24 | Baranick Brian | Direct Ownership | Common Stock | S - Open market or private sale | -924 | $79.43 |
Apr 3/24 | Apr 1/24 | Condella Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -2,000 | $70.00 |
Apr 1/24 | Mar 28/24 | Condella Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -2,000 | $70.00 |
Mar 4/24 | Mar 1/24 | Orville Jacob A | Direct Ownership | Common Stock | S - Open market or private sale | -2,154 | $59.32 |
Mar 4/24 | Mar 1/24 | Levangie Daniel J | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $57.50 |
Mar 4/24 | Mar 1/24 | Herriott James | Direct Ownership | Common Stock | S - Open market or private sale | -862 | $59.32 |
Mar 4/24 | Mar 1/24 | Elliott Jeffrey Thomas | Direct Ownership | Common Stock | S - Open market or private sale | -2,412 | $59.32 |
Mar 4/24 | Mar 1/24 | Doyle James Edward | Direct Ownership | Common Stock | S - Open market or private sale | -2,000 | $57.50 |
Mar 4/24 | Mar 1/24 | Cunningham Everett | Direct Ownership | Common Stock | S - Open market or private sale | -2,412 | $59.32 |
Mar 4/24 | Mar 1/24 | Conroy Kevin T | Direct Ownership | Common Stock | S - Open market or private sale | -8,271 | $59.32 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for EXAS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Condella Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -2,000 | $70.00 |
Apr 3/24 | Apr 2/24 | Baranick Brian | Direct Ownership | Common Stock | S - Open market or private sale | -924 | $79.43 |
Apr 1/24 | Mar 28/24 | Condella Sarah | Direct Ownership | Common Stock | S - Open market or private sale | -2,000 | $70.00 |
Mar 4/24 | Feb 29/24 | Orville Jacob A | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -4,724 | |
Mar 4/24 | Mar 1/24 | Orville Jacob A | Direct Ownership | Common Stock | S - Open market or private sale | -2,154 | $59.32 |
Mar 4/24 | Feb 29/24 | Orville Jacob A | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 4,724 | |
Mar 4/24 | Mar 1/24 | Levangie Daniel J | Direct Ownership | Common Stock | S - Open market or private sale | -5,000 | $57.50 |
Mar 4/24 | Feb 29/24 | Herriott James | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -1,890 | |
Mar 4/24 | Mar 1/24 | Herriott James | Direct Ownership | Common Stock | S - Open market or private sale | -862 | $59.32 |
Mar 4/24 | Feb 29/24 | Herriott James | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,890 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Iovance Biotherapeutics (OQ:IOVA) |
Adaptive Biotechnologies (OQ:ADPT) |
Veracyte (OQ:VCYT) |